Idarucizumab News
Idarucizumab currently has 3 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Idarucizumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Praxbind is a specific reversal agent for dabigatran and is indicated in adult patients treated with Pradaxa (dabigatran etexilate) when rapid reversal of its anticoagulant effects is required: for...
- Evidence level: L5
- Predicted indications (20):
- hemoglobinopathy (95.7%)
- rheumatoid arthritis (95.5%)
- partial deletion of the short arm of chromosome 16 (95.0%)
- beta-thalassemia with other manifestations (95.0%)
- pyruvate kinase deficiency of red cells (94.8%)
- hemolytic anemia due to glucophosphate isomerase deficiency (94.6%)
- pyropoikilocytosis, hereditary (94.3%)
- bronchitis (94.1%)
- gout (93.8%)
- colobomatous microphthalmia-rhizomelic dysplasia syndrome (93.6%)
- osteoarthritis (93.5%)
- antithrombin deficiency type 2 (92.8%)
- osteoarthritis susceptibility (92.7%)
- heparin cofactor 2 deficiency (92.7%)
- factor 5 excess with spontaneous thrombosis (92.5%)
- brachydactyly-syndactyly syndrome (92.2%)
- pseudoachondroplasia (91.5%)
- thrombophilia (91.4%)
- hepatic porphyria (91.0%)
- myocardial infarction (90.8%)
Related News (3)
A surprisingly simple way to relieve knee arthritis pain without pills or surgery - Science Daily
2026-10-11 arthritis
Source: Science Daily
Vous êtes fatigué en ce début d’automne ? C’est normal mais vous pouvez y remédier - Le HuffPost
2026-10-10 EPOC
Source: Le HuffPost
Knee pain and crunching: 3 exercises to ease osteoarthritis of the kneecap - South China Morning Post
2026-10-09 arthritis
Source: South China Morning Post
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.